Human Microbiome Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Human Microbiome Market
1.1. Definition and Scope
1.1.1. Definition of Human Microbiome
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Human Microbiome Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Human Microbiome Market By Product
1.2.3. Human Microbiome Market By Disease
1.2.4. Human Microbiome Market By Application
1.2.5. Human Microbiome Market By Distribution Channel
1.2.6. Human Microbiome Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Human Microbiome Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Human Microbiome Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Human Microbiome Market By Product
5.1. Introduction
5.2. Human Microbiome Revenue By Product
5.2.1. Human Microbiome Revenue (USD Million) and Forecast, By Product, 2020-2032
5.2.2. Probiotics
5.2.2.1. Probiotics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Prebiotics
5.2.3.1. Prebiotics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Medical Foods
5.2.4.1. Medical Foods Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Diagnostic Device
5.2.5.1. Diagnostic Device Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.6. Drugs
5.2.6.1. Drugs Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.7. Supplements
5.2.7.1. Supplements Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Human Microbiome Market By Disease
6.1. Introduction
6.2. Human Microbiome Revenue By Disease
6.2.1. Human Microbiome Revenue (USD Million) and Forecast, By Disease, 2020-2032
6.2.2. Obesity
6.2.2.1. Obesity Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Diabetes
6.2.3.1. Diabetes Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Autoimmune Disorders
6.2.4.1. Autoimmune Disorders Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Cancer
6.2.5.1. Cancer Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.6. Mental Disorders
6.2.6.1. Mental Disorders Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.7. Others
6.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Human Microbiome Market By Application
7.1. Introduction
7.2. Human Microbiome Revenue By Application
7.2.1. Human Microbiome Revenue (USD Million) and Forecast, By Application, 2020-2032
7.2.2. Therapeutics
7.2.2.1. Therapeutics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Diagnostics
7.2.3.1. Diagnostics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. Human Microbiome Market By Distribution Channel
8.1. Introduction
8.2. Human Microbiome Revenue By Distribution Channel
8.2.1. Human Microbiome Revenue (USD Million) and Forecast, By Distribution Channel, 2020-2032
8.2.2. Supermarket & Hypermarket
8.2.2.1. Supermarket & Hypermarket Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.3. Retail Pharmacies
8.2.3.1. Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.4. Online Pharmacies
8.2.4.1. Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Human Microbiome Market By Country
9.1. North America Human Microbiome Market Overview
9.2. U.S.
9.2.1. U.S. Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
9.2.2. U.S. Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
9.2.3. U.S. Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
9.2.4. U.S. Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.3. Canada
9.3.1. Canada Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
9.3.2. Canada Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
9.3.3. Canada Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
9.3.4. Canada Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Human Microbiome Market By Country
10.1. Europe Human Microbiome Market Overview
10.2. U.K.
10.2.1. U.K. Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
10.2.2. U.K. Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
10.2.3. U.K. Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
10.2.4. U.K. Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.3. Germany
10.3.1. Germany Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
10.3.2. Germany Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
10.3.3. Germany Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
10.3.4. Germany Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.4. France
10.4.1. France Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
10.4.2. France Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
10.4.3. France Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
10.4.4. France Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.5. Spain
10.5.1. Spain Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
10.5.2. Spain Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
10.5.3. Spain Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
10.5.4. Spain Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
10.6.2. Rest of Europe Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
10.6.3. Rest of Europe Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
10.6.4. Rest of Europe Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Human Microbiome Market By Country
11.1. Asia Pacific Human Microbiome Market Overview
11.2. China
11.2.1. China Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
11.2.2. China Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
11.2.3. China Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
11.2.4. China Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.3. Japan
11.3.1. Japan Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
11.3.2. Japan Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
11.3.3. Japan Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
11.3.4. Japan Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.4. India
11.4.1. India Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
11.4.2. India Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
11.4.3. India Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
11.4.4. India Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.5. Australia
11.5.1. Australia Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
11.5.2. Australia Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
11.5.3. Australia Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
11.5.4. Australia Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.6. South Korea
11.6.1. South Korea Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
11.6.2. South Korea Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
11.6.3. South Korea Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
11.6.4. South Korea Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
11.7.2. Rest of Asia-Pacific Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
11.7.3. Rest of Asia-Pacific Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
11.7.4. Rest of Asia-Pacific Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Human Microbiome Market By Country
12.1. Latin America Human Microbiome Market Overview
12.2. Brazil
12.2.1. Brazil Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
12.2.2. Brazil Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
12.2.3. Brazil Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
12.2.4. Brazil Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.3. Mexico
12.3.1. Mexico Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
12.3.2. Mexico Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
12.3.3. Mexico Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
12.3.4. Mexico Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
12.4.2. Rest of Latin America Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
12.4.3. Rest of Latin America Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
12.4.4. Rest of Latin America Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Human Microbiome Market By Country
13.1. Middle East & Africa Human Microbiome Market Overview
13.2. GCC
13.2.1. GCC Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
13.2.2. GCC Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
13.2.3. GCC Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
13.2.4. GCC Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.3. South Africa
13.3.1. South Africa Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
13.3.2. South Africa Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
13.3.3. South Africa Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
13.3.4. South Africa Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Human Microbiome Revenue (USD Million) and Forecast By Product, 2020-2032
13.4.2. Rest of Middle East & Africa Human Microbiome Revenue (USD Million) and Forecast By Disease, 2020-2032
13.4.3. Rest of Middle East & Africa Human Microbiome Revenue (USD Million) and Forecast By Application, 2020-2032
13.4.4. Rest of Middle East & Africa Human Microbiome Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Human Microbiome Market
14.1. Human Microbiome Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Human Microbiome Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Merck
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Million), 2022
15.1.3.2. Merck 2022 Human Microbiome Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Yakult
15.3. DuPont
15.4. Enterome Bioscience
15.5. ViThera Pharmaceuticals
15.6. Second Genome Inc.
15.7. Vedanta BioSciences
15.8. Microbiome Therapeutics LLC
15.9. Osel
15.10. Metabiomics Corporation
Frequently Asked Questions
How big is the human microbiome market?
The human microbiome market was USD 154.8 million in 2022.
What is the CAGR of the global human microbiome market from 2023 to 2032?
The CAGR of human microbiome is 30.7% during the analysis period of 2023 to 2032.
Which are the key players in the human microbiome market?
The key players operating in the global market are including Merck, Yakult, DuPont, Enterome Bioscience, ViThera Pharmaceuticals, Second Genome Inc., Vedanta BioSciences, Microbiome Therapeutics LLC, Osel, and Metabiomics Corporation.
Which region dominated the global human microbiome market share?
North America held the dominating position in human microbiome industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of human microbiome during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global human microbiome industry?
The current trends and dynamics in the human microbiome industry include increasing awareness of the impact of the human microbiome on health, advances in metagenomics and microbiome research techniques, growing prevalence of chronic diseases requiring microbiome-based therapies, and rising investments in microbiome-based therapeutic and diagnostic research.
Which application held the maximum share in 2022?
The therapeutics application held the maximum share of the human microbiome industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
